Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.

Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C.

Intervirology. 2018;61(4):166-173. doi: 10.1159/000494354. Epub 2019 Jan 17.

PMID:
30654366
2.

Antimicrobial peptides with antiprotozoal activity: current state and future perspectives.

Giovati L, Ciociola T, Magliani W, Conti S.

Future Med Chem. 2018 Nov;10(22):2569-2572. doi: 10.4155/fmc-2018-0460. Epub 2018 Nov 30. No abstract available.

3.

Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide.

Pertinhez TA, Ciociola T, Giovati L, Magliani W, Belletti S, Polonelli L, Conti S, Spisni A.

Int J Mol Sci. 2018 Nov 28;19(12). pii: E3792. doi: 10.3390/ijms19123792.

4.

Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases.

Annunziato G, Giovati L, Angeli A, Pavone M, Del Prete S, Pieroni M, Capasso C, Bruno A, Conti S, Magliani W, Supuran CT, Costantino G.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1537-1544. doi: 10.1080/14756366.2018.1516652.

5.

Novel Activity of a Synthetic Decapeptide Against Toxoplasma gondii Tachyzoites.

Giovati L, Santinoli C, Mangia C, Vismarra A, Belletti S, D'Adda T, Fumarola C, Ciociola T, Bacci C, Magliani W, Polonelli L, Conti S, Kramer LH.

Front Microbiol. 2018 Apr 20;9:753. doi: 10.3389/fmicb.2018.00753. eCollection 2018.

6.

Fungicidal activity of peptides encoded by immunoglobulin genes.

Polonelli L, Ciociola T, Sperindè M, Giovati L, D'Adda T, Galati S, Travassos LR, Magliani W, Conti S.

Sci Rep. 2017 Sep 7;7(1):10896. doi: 10.1038/s41598-017-11396-6.

7.

The synthetic killer peptide KP impairs Candida albicans biofilm in vitro.

Paulone S, Ardizzoni A, Tavanti A, Piccinelli S, Rizzato C, Lupetti A, Colombari B, Pericolini E, Polonelli L, Magliani W, Conti S, Posteraro B, Cermelli C, Blasi E, Peppoloni S.

PLoS One. 2017 Jul 13;12(7):e0181278. doi: 10.1371/journal.pone.0181278. eCollection 2017.

8.

Idiotypic Antifungal Vaccination: Immunoprotection by Antiidiotypic Antibiotic Antibodies.

Polonelli L, Magliani W, Conti S.

Methods Mol Biol. 2017;1625:97-112. doi: 10.1007/978-1-4939-7104-6_8.

PMID:
28584986
9.

Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP).

Ferrari L, Borghetti P, Ferrarini G, De Angelis E, Canelli E, Ogno G, Catella A, Ciociola T, Magliani W, Martelli P.

Res Vet Sci. 2016 Dec;109:29-39. doi: 10.1016/j.rvsc.2016.09.008. Epub 2016 Sep 14.

PMID:
27892871
10.

A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents.

Polonelli L, Ciociola T, Elviri L, Zanello PP, Giovati L, Arruda DC, Muñoz JE, Mortara RA, Morace G, Borghi E, Galati S, Marin O, Casoli C, Pilotti E, Ronzi P, Travassos LR, Magliani W, Conti S.

Sci Rep. 2016 Oct 11;6:35018. doi: 10.1038/srep35018.

11.

Natural and synthetic peptides with antifungal activity.

Ciociola T, Giovati L, Conti S, Magliani W, Santinoli C, Polonelli L.

Future Med Chem. 2016 Aug;8(12):1413-33. doi: 10.4155/fmc-2016-0035. Epub 2016 Aug 9. Review.

PMID:
27502155
12.

Dissecting the Structure-Function Relationship of a Fungicidal Peptide Derived from the Constant Region of Human Immunoglobulins.

Ciociola T, Pertinhez TA, Giovati L, Sperindè M, Magliani W, Ferrari E, Gatti R, D'Adda T, Spisni A, Conti S, Polonelli L.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2435-42. doi: 10.1128/AAC.01753-15. Print 2016 Apr.

13.

AFM₁ in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination.

Giovati L, Magliani W, Ciociola T, Santinoli C, Conti S, Polonelli L.

Toxins (Basel). 2015 Oct 23;7(10):4330-49. doi: 10.3390/toxins7104330. Review.

14.

Antibodies as a source of anti-infective peptides: an update.

Magliani W, Giovati L, Ciociola T, Sperindè M, Santinoli C, Conti G, Conti S, Polonelli L.

Future Microbiol. 2015;10(7):1163-75. doi: 10.2217/fmb.15.36. Epub 2015 Jun 29. Review.

PMID:
26119210
15.

Peptides from the inside of the antibodies are active against infectious agents and tumours.

Ciociola T, Giovati L, Sperindè M, Magliani W, Santinoli C, Conti G, Conti S, Polonelli L.

J Pept Sci. 2015 May;21(5):370-8. doi: 10.1002/psc.2748. Epub 2015 Mar 10. Review.

PMID:
25756615
16.

Antibodies as an unlimited source of anti-infective, anti-tumour and immunomodulatory peptides.

Ciociola T, Magliani W, Giovati L, Sperindé M, Santinoli C, Conti G, Conti S, Polonella L.

Sci Prog. 2014;97(Pt 3):215-33. Review.

PMID:
25549407
17.

Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.

Polonelli L, Beninati C, Teti G, Felici F, Ciociola T, Giovati L, Sperindè M, Lo Passo C, Pernice I, Domina M, Arigò M, Papasergi S, Mancuso G, Conti S, Magliani W.

PLoS One. 2014 Aug 27;9(8):e105727. doi: 10.1371/journal.pone.0105727. eCollection 2014.

18.

Vaccination of heifers with anaflatoxin improves the reduction of aflatoxin b1 carry over in milk of lactating dairy cows.

Giovati L, Gallo A, Masoero F, Cerioli C, Ciociola T, Conti S, Magliani W, Polonelli L.

PLoS One. 2014 Apr 8;9(4):e94440. doi: 10.1371/journal.pone.0094440. eCollection 2014.

19.

In vitro and in vivo activity of a killer peptide against Malassezia pachydermatis causing otitis in dogs.

Cafarchia C, Immediato D, Paola GD, Magliani W, Ciociola T, Conti S, Otranto D, Polonelli L.

Med Mycol. 2014 May;52(4):350-5. doi: 10.1093/mmy/myt016. Epub 2014 Feb 28.

PMID:
24625672
20.

Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food.

Zanello PP, Sforza S, Dossena A, Lambertini F, Bottesini C, Nikolaev IV, Koroleva O, Ciociola T, Magliani W, Conti S, Polonelli L.

Food Funct. 2014 Feb;5(2):220-8. doi: 10.1039/c3fo60454c.

PMID:
24284558
21.

Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway.

Gabrielli E, Pericolini E, Cenci E, Monari C, Magliani W, Ciociola T, Conti S, Gatti R, Bistoni F, Polonelli L, Vecchiarelli A.

PLoS One. 2012;7(8):e43972. doi: 10.1371/journal.pone.0043972. Epub 2012 Aug 27.

22.

Antibody Peptide based antifungal immunotherapy.

Magliani W, Conti S, Giovati L, Zanello PP, Sperindè M, Ciociola T, Polonelli L.

Front Microbiol. 2012 Jun 1;3:190. doi: 10.3389/fmicb.2012.00190. eCollection 2012.

23.

Peptides of the constant region of antibodies display fungicidal activity.

Polonelli L, Ciociola T, Magliani W, Zanello PP, D'Adda T, Galati S, De Bernardis F, Arancia S, Gabrielli E, Pericolini E, Vecchiarelli A, Arruda DC, Pinto MR, Travassos LR, Pertinhez TA, Spisni A, Conti S.

PLoS One. 2012;7(3):e34105. doi: 10.1371/journal.pone.0034105. Epub 2012 Mar 21.

24.

Vaccination of lactating dairy cows for the prevention of aflatoxin B1 carry over in milk.

Polonelli L, Giovati L, Magliani W, Conti S, Sforza S, Calabretta A, Casoli C, Ronzi P, Grilli E, Gallo A, Masoero F, Piva G.

PLoS One. 2011;6(10):e26777. doi: 10.1371/journal.pone.0026777. Epub 2011 Oct 28.

25.

Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.

Magliani W, Conti S, Ciociola T, Giovati L, Zanello PP, Pertinhez T, Spisni A, Polonelli L.

Future Med Chem. 2011 Jul;3(9):1209-31. doi: 10.4155/fmc.11.71. Review.

PMID:
21806382
26.

From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy.

Polonelli L, Magliani W, Ciociola T, Giovati L, Conti S.

Antonie Van Leeuwenhoek. 2011 Jan;99(1):35-41. doi: 10.1007/s10482-010-9496-3. Epub 2010 Aug 18.

PMID:
20714805
27.

Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells.

Dobroff AS, Rodrigues EG, Juliano MA, Friaça DM, Nakayasu ES, Almeida IC, Mortara RA, Jacysyn JF, Amarante-Mendes GP, Magliani W, Conti S, Polonelli L, Travassos LR.

Transl Oncol. 2010 Aug 1;3(4):204-17.

28.

Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Gabrielli E, Pericolini E, Cenci E, Ortelli F, Magliani W, Ciociola T, Bistoni F, Conti S, Vecchiarelli A, Polonelli L.

PLoS One. 2009 Dec 4;4(12):e8187. doi: 10.1371/journal.pone.0008187.

29.

Antibodies as crypts of antiinfective and antitumor peptides.

Magliani W, Conti S, Cunha RL, Travassos LR, Polonelli L.

Curr Med Chem. 2009;16(18):2305-23. Review.

PMID:
19519392
30.

Reversible self-assembly: a key feature for a new class of autodelivering therapeutic peptides.

Pertinhez TA, Conti S, Ferrari E, Magliani W, Spisni A, Polonelli L.

Mol Pharm. 2009 May-Jun;6(3):1036-9. doi: 10.1021/mp900024z.

PMID:
19366260
31.

Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.

Conti G, Magliani W, Conti S, Nencioni L, Sgarbanti R, Palamara AT, Polonelli L.

Antimicrob Agents Chemother. 2008 Dec;52(12):4331-7. doi: 10.1128/AAC.00506-08. Epub 2008 Sep 29.

32.

From yeast killer toxins to antibiobodies and beyond.

Magliani W, Conti S, Travassos LR, Polonelli L.

FEMS Microbiol Lett. 2008 Nov;288(1):1-8. doi: 10.1111/j.1574-6968.2008.01340.x. Review.

33.

Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.

Polonelli L, Pontón J, Elguezabal N, Moragues MD, Casoli C, Pilotti E, Ronzi P, Dobroff AS, Rodrigues EG, Juliano MA, Maffei DL, Magliani W, Conti S, Travassos LR.

PLoS One. 2008 Jun 11;3(6):e2371. doi: 10.1371/journal.pone.0002371.

34.

Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies.

Magliani W, Conti S, Giovati L, Maffei DL, Polonelli L.

Front Biosci. 2008 May 1;13:6920-37.

PMID:
18508705
35.

Screening of a Saccharomyces cerevisiae nonessential gene deletion collection for altered susceptibility to a killer peptide.

Conti S, Magliani W, Giovati L, Libri I, Maffei DL, Salati A, Polonelli L.

New Microbiol. 2008 Jan;31(1):143-5.

36.

A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.

Casoli C, Pilotti E, Perno CF, Balestra E, Polverini E, Cassone A, Conti S, Magliani W, Polonelli L.

AIDS. 2006 Apr 24;20(7):975-80.

PMID:
16603848
37.

In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide.

Fiori PL, Mattana A, Dessì D, Conti S, Magliani W, Polonelli L.

J Antimicrob Chemother. 2006 May;57(5):891-8. Epub 2006 Feb 28.

PMID:
16507561
38.

Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes.

Savoia D, Scutera S, Raimondo S, Conti S, Magliani W, Polonelli L.

Exp Parasitol. 2006 Jul;113(3):186-92. Epub 2006 Feb 17.

PMID:
16487518
39.

Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci.

Beninati C, Midiri A, Mancuso G, Biondo C, Arigò M, Gerace E, Papasergi S, Gambuzza M, Boretti M, Magliani W, Conti S, Polonelli L, Teti G.

J Exp Med. 2006 Jan 23;203(1):111-8. Epub 2006 Jan 3.

40.

Antibody-mediated protective immunity in fungal infections.

Magliani W, Conti S, Arseni S, Salati A, Ravanetti L, Maffei DL, Giovati L, Polonelli L.

New Microbiol. 2005 Oct;28(4):299-309. Review.

PMID:
16386014
41.

Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide.

Cenci E, Pericolini E, Mencacci A, Conti S, Magliani W, Bistoni F, Polonelli L, Vecchiarelli A.

J Leukoc Biol. 2006 Jan;79(1):40-5. Epub 2005 Oct 21.

PMID:
16244115
42.

Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.

Donini M, Lico C, Baschieri S, Conti S, Magliani W, Polonelli L, Benvenuto E.

Appl Environ Microbiol. 2005 Oct;71(10):6360-7.

43.

Protective antifungal yeast killer toxin-like antibodies.

Magliani W, Conti S, Frazzi R, Ravanetti L, Maffei DL, Polonelli L.

Curr Mol Med. 2005 Jun;5(4):443-52. Review.

PMID:
15978000
44.

Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis.

Travassos LR, Silva LS, Rodrigues EG, Conti S, Salati A, Magliani W, Polonelli L.

J Antimicrob Chemother. 2004 Nov;54(5):956-8. Epub 2004 Sep 24.

PMID:
15448128
45.

Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.

Magliani W, Conti S, Salati A, Vaccari S, Ravanetti L, Maffei DL, Polonelli L.

FEMS Yeast Res. 2004 Oct;5(1):11-8. Review.

46.

A synthetic peptide as a novel anticryptococcal agent.

Cenci E, Bistoni F, Mencacci A, Perito S, Magliani W, Conti S, Polonelli L, Vecchiarelli A.

Cell Microbiol. 2004 Oct;6(10):953-61.

PMID:
15339270
47.

Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy.

Magliani W, Conti S, Salati A, Arseni S, Ravanetti L, Frazzi R, Polonelli L.

Curr Med Chem. 2004 Jul;11(13):1793-800. Review.

PMID:
15279582
48.

Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.

Beninati C, Arseni S, Mancuso G, Magliani W, Conti S, Midiri A, Biondo C, Polonelli L, Teti G.

J Immunol. 2004 Feb 15;172(4):2461-8.

49.

Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Polonelli L, Magliani W, Conti S, Bracci L, Lozzi L, Neri P, Adriani D, De Bernardis F, Cassone A.

Infect Immun. 2003 Nov;71(11):6205-12.

50.

New strategies for treatment of Candida vaginal infections.

Magliani W, Conti S, Salati A, Arseni S, Frazzi R, Ravanetti L, Polonelli L.

Rev Iberoam Micol. 2002 Sep;19(3):144-8.

Supplemental Content

Loading ...
Support Center